NCT04444076View on ClinicalTrials.gov

Clinical Trial on the Effect of REGENETEN Bioinductive Implant in the Supraspinatus Tendon Repair

NAActive, not recruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Supraspinatus Tear
Interventions
DEVICE

REGENETEN Bioinductive Implant

REGENETEN bioinductive Implant,a reconstituted bovine origin type I collagen mesh with a proprietary high porosity system that is commercialized sterile, dehydrated and desiccated in two sizes (20x26mm and 25x31mm). It will be implanted following supraspinatus tendon repair.

Trial Locations (1)

28034

Hospital Ramón y Cajal, Madrid

All Listed Sponsors
lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER